About DendreonDendreon Corporation is a biotechnology company.

About DendreonDendreon Corporation is a biotechnology company, hyperplasia.on is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The company applies its expertise in antigen identification, engineering and cell to active cellular immunotherapy product candidates designed stimulate an immune response in order to stimulate an immune response. Dendreon is also developing an orally-available small molecule called Trp-p8 that could for several types of cancer and benign prostatic hyperplasia. The company is headquartered in Seattle, Washington and on the Nasdaq Global on the Nasdaq Global Market under the symbol DNDN. For more information about the company and its programs, visit..

Among the factors that could cause such differences include risks related to our limited operating history, risks associated with completing our clinical trials, the risk that the safety and / or efficacy results of existing clinical trials or from additional clinical trials for PROVENGE will not support approval for a biologics license, the risk that the FDA may interpret data differently than we or require further information or a detailed analysis of data than expected, the risk that the FDA may not approve a product for which a biologics license been applied is to do the risk that the results of of a clinical trial for PROVENGE or other product areas may not be indicative of results in later clinical trials, risks that we need the financial resources and access to capital for clinical trials or commercialization of PROVENGE funds, a 20 %nce on the efforts of the missing might get a third party, and our dependence on intellectual property.A health care professional adopted a new Direct-To-Consumer Genetic Testing Policy Recommendation.

To his 17 Jun. Annual Meeting, the American Medical Association , the greatest medical group in the U.S., policy advice opposing direct-to consumer genetic tests. Which recommendations mean that a physician should be integrated into the genetic test, and encouraging individual in raising genetic tests to contact one physician interested. Output briefly – Direct – to-consumer genetic test: reinforce or risk the public?